Related Experiment Video
Updated: May 16, 2026
03:32
A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
Published on: April 12, 2019
Pleural effusion in aluminum phosphide poisoning
Kranti Garg1, Prasanta R Mohapatra, Mandeep K Sodhi
1Department of Pulmonary Medicine, Government Medical College and Hospital, Chandigarh, India.
Lung India : Official Organ of Indian Chest Society
|December 18, 2012
Summary
Aluminium phosphide (ALP) poisoning can cause serious complications. This case highlights pleural effusion as a rare manifestation that resolved with patient recovery.
Area of Science:
- Toxicology
- Internal Medicine
- Pulmonology
Background:
- Aluminium phosphide (ALP) is a widely used pesticide in agriculture.
- ALP poisoning is associated with significant morbidity and mortality.
- Cardiac and gastrointestinal symptoms are the most common clinical presentations of ALP poisoning.
Purpose of the Study:
- To report a rare case of pleural effusion secondary to aluminium phosphide ingestion.
- To discuss the clinical course and management of this specific complication.
- To add to the literature on the diverse manifestations of ALP poisoning.
Main Methods:
- A case report detailing the clinical presentation, diagnostic workup, and management of a patient with ALP poisoning.
- Review of relevant medical literature regarding pleural effusion in ALP poisoning.
Main Results:
- The patient developed significant pleural effusion following ALP ingestion.
- The pleural effusion resolved gradually as the patient recovered from the acute poisoning.
- No specific intervention for the pleural effusion was required beyond supportive care for ALP poisoning.
Conclusions:
- Pleural effusion, though uncommon, can occur in aluminium phosphide poisoning.
- Resolution of pleural effusion correlates with the overall recovery from ALP toxicity.
- Clinicians should be aware of this potential complication in patients with ALP poisoning.
Related Concept Videos
01:28Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:25Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
01:08Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:30Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...